Back

Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Advances in ATTR amyloidosis Heart Failure with Preserved Ejection Fraction (HFpEF) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Daniela Tomasoni

Spedali Civili, University Of Brescia, Brescia (Italy)

3 More presentations in this session

Presentation thumbnail
State-of-the-art lecture in ATTR amyloidosis.
Professor M. Fontana (London, GB)
Slides Video
Presentation thumbnail
Epidemiology of cardiac amyloidosis and burden on health care system in Germany: a retrospective analysis from 2009 to 2018
Associate Professor R. Pfister (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Plasma amyloid-beta in relation to cardiac function and risk of heart failure in the general population
Mrs F. Zhu (Rotterdam, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in ATTR amyloidosis
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Cardiovascular prognosis in stable patients with amyloidosis: a novel and simple risk score.
thumbnail
Congress Presentation
The value of scoring systems in terms of phenogroups in the diagnosis of heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Three rules to find them all: clinical risk scores in heart failure with preserved ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources